A food effect and relative bioavailability study of rilzabrutinib in healthy participants

Trial Identifier:	PKM18138
Sponsor:	Sanofi
Start Date:	March 2024
Primary Completion Date:	April 2024
Study Completion Date:	April 2024
Condition:	Healthy Volunteers; Immune, Inflammatory & Infections - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
UNITED STATES, Minnesota	St. Paul, Minnesota, UNITED STATES, 55114

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.